Successful German market entry and deepening of exclusive Partnership

(© Medical Pharma Resource GmbH &  Images ©: https://de.123rf.com/profile_istanbul2009; https://de.123rf.com/profile_solerf)

Langenfeld, 2202-04-11
  • Successful market entry of Medical Pharma Resource (Medical Pharma) and Beacon Medical Germany with Beacon I-Hybrid THC 18 – Wappa in Germany.
  • Medical Pharma and Beacon Medical Germany deepen their exclusive partnership and provide German patients with additional therapeutic options based on the new strain Beacon Indica THC 18 – Sensi Star
  • Medical Pharma expands their product portfolio with the cannabis strain Bedrocan® 22/1, Dronabinol- and the Cannabidiol-Kits

The German market entry of the first exclusive product from Beacon Medical Germany is going very well for both partners. The Beacon I-Hybrid THC 18 – Wappa was previously not available in Germany and is very well requested by treating physicians and patients as a result of the excellent quality.

Medical Pharma and Beacon Medical Germany set on high-quality and full transparency for the imported cannabis products from Canada. Offering up-to-date terpene analyses for the imported batches will help the treating physicians and, above all, the patients to receive an efficient therapy.

The next important milestone for both partners is the timely launch of Beacon Indica THC 18 – Sensi Star from Canada. This new cultivar from Beacon Medical Germany was also not available in Germany before and will provide treating physicians and patients with new therapy options.

Engin Ates, CEO and Co-Founder of Medical Pharma, says: “Our long experience and close collaboration with VIVO’s German subsidiary, Beacon Medical Germany GmbH, will ensure for patients in Germany a new quality standard in medical cannabis therapy. With Harvest Medicine, VIVO’s patient-centered network of medical cannabis clinics that has served over 150,000 patient visits, we will continue to provide treating physicians and patients in Germany with new therapeutic options in the form of medicinal cannabis flowers.”

Medical Pharma will expand by Fall the product portfolio with the strain Bedrocan® 22/1, Dronabinol- and Cannabidiol-Kits to support the therapies and treatments in Germany.

The successful launch of the partnership between Medical Pharma Resource GmbH and Beacon Medical Germany GmbH is the foundations for a long collaboration. New cannabis products from Beacon’s large Canadian product portfolio will follow. Which products exactly will stay a secret of both companies for the time being.

 

About Medical Pharma Resource ®

Medical Pharma Resource (MPR) GmbH was founded at the end of 2018 and is based in Langenfeld. Our pharmaceutical wholesale is focussed on the import, storage, manufacturing, distribution and export of prescription medical cannabis products and therapeutic devices.

We are licensed pharmaceutical wholesalers according to § 52a of the German Medicines Act (AMG) and have a permit to handle narcotics according to § 3 of the Federal Institute for Drugs and Medical Devices (BtMG).

The official inspection for obtaining the manufacturing license in accordance with § 13 AMG and the import license according to § 72 AMG was already carried out by the responsible District Government in February 2022.

 

The philosophy of Medical Pharma

Our company philosophy is simple. Our goal is to provide German patients with high-quality, transparent and traceable medical cannabis products in a timely and sustainable manner.

We are committed to consider important quality criteria in the selection of manufacturers and products, in order to provide the treating physicians and especially the patients with enhanced therapy options.

The Medical Pharma distribution platform offers the own products, the partner products from all over the world and also specific products from German competitors.

 

About VIVO Cannabis ™

VIVO Cannabis is recognized for trusted, premium cannabis products and services in Canada It holds cultivation, processing and sales licenses from Health Canada and operates world-class state of the art indoor and seasonal cultivation facilities. VIVO has a collection of premium brands in Canada, each targeting different customer segments, including Canna Farms ™, Beacon Medical ™, Fireside ™, Fireside-X ™ and Lumina ™. Harvest Medicine ™, VIVO’s client-centric, scalable network of medical cannabis clinics, has serviced over 150,000 patient visits. VIVO is pursuing several partnership and product development opportunities and is focusing its international efforts on Germany and Australia.
For more information, visit: VIVO Cannabis Inc. and Beacon Medical Germany

Business partner

We invite you to join us as a partner with your resources and participate proactively in the supply chain of the German & EU medical cannabis market. A good medical alternative with fewer risks and side effects.
As a partner we can guarantee you security, continuity, transparency and trust.
Contact:
business(@)mp-resource(.)com
Internal forwarding: Click on “CONTINUE” please

PR-Contact

Dr. Daniel König
+49 (0) 2173 940 95 91
presse(@)mp-resource(.)com

Medical Pharma brings new exclusive strain to German pharmacies shortly before Christmas

(© Medical Pharma Resource GmbH – Using Pictures ©: https://de.123rf.com/profile_istanbul2009; https://de.123rf.com/profile_feellgood/)
Langenfeld, 12/15/2021

Medical Pharma Resource GmbH (Medical Pharma) based in Langenfeld (Rhld.) is starting to distribute a new medical cannabis product from Canada on the German market. With a view to providing this high-quality medicine to patients throughout Germany via pharmacies, Medical Pharma has signed an exclusive partnership with Beacon Medical Germany.

Medical Pharma promotes high quality cannabis products-based treatment methods that target unmet medical needs of patients. The company sees great potential in the treatment of various disease symptoms through numerous international research results on phytocannabinoids.

Since the company was founded, national and international collaborations have been established in this regard with partners in the areas of analytical testing, narcotics manufacturing, narcotics storage, cannabis producers and logistics. Medical Pharma is still in international negotiations with various producers from different countries to import, manufacture and distribute products under the brand name “MPRCanna®” and partner products.

In line with this, the company prepared internally for the granting of the manufacturing license according to § 13 AMG and for the import license according to § 72 AMG. The preparations were completed at the end of October 2021. The company is currently awaiting written confirmation of the date for the inspection by the authorities. By the end of February 2022, Medical Pharma is expected to have all licenses to import its own products and those of its partners.

The exclusive partner, Beacon Medical Germany GmbH, is a German subsidiary of Canada-based VIVO Cannabis Inc.

The exchange listed VIVO Cannabis Inc. is a Canadian company that is active in the cultivation, production and marketing of cannabis products. Its subsidiary ABcann Medicinals owns a medical cannabis flower production facility in Napanee – Ontario, Canada. In March ABcann Medicinals’ Vanluven facility has received EU-GMP certification in accordance with GMP Vol. 4 – Part 1, by the Brandenburg Health Authority, the State Office for Occupational Safety, Consumer Protection and Health (“LAVG “). The certification allows VIVO, through ABcann Medicinals, to export products for sale in European and other markets for which products must be manufactured according to strict GMP standards.

At the same time, Beacon Medical Germany GmbH received an import license from the authority to import Napanee medical cannabis flowers into Germany and the EU.

The exclusive partnership with VIVO’s German subsidiary, Beacon Medical Germany GmbH, is a great strategic success for both partners. Our many years of experience will ensure that new quality standards in therapy with medical cannabis are set for patients in Germany. Through its Harvest Medicine subsidiary, a patient-centered network of medical cannabis clinics owned by VIVO over 150,000 patient visits have been managed, explains Engin Ates, CEO and Co-Founder of Medical Pharma Resource GmbH, who has also been successfully participating in cannabis therapy as a pain patient himself for years.

Public Relations Medical Pharma Resource

Dr. Daniel König
+49 (0) 2173 940 95 91
presse(ät)mp-resource(.)com

About Medical Pharma Resource ®

Medical Pharma Resource (Medical Pharma) GmbH was founded at the end of 2018 and is based in Langenfeld, Germany. The focus of this pharmaceutical company is the import and distribution of prescription medical cannabis products and applicators.
Medical Pharma is a licensed pharmaceutical wholesaler according to § 52a of the German Medicines Act (AMG) and has the permission to handle narcotics according to § 3 of the German Narcotics Act (BtMG).
Further, the internal preparations are completed for the granting of the manufacturing license according to § 13 AMG and the import license according to § 72 AMG. Medical Pharma expects to receive all licenses by the end of February 2022.

The philosophy of Medical Pharma

The core of Medical Pharma philosophy is to provide patients with new high quality medicinal cannabis flowers.
Medical Pharma Resource GmbH has taken the goal to consider the criteria that are important for the well-being of patients when selecting manufacturers in order to ensure the highest level of quality, efficacy, transparency and availability.
The partner products, the own products and also selectively products of the German competitors can be offered via Medical Pharma’s own sales platform.
For more information, please visit: Medical Pharma Resource

About VIVO Cannabis ™

VIVO Cannabis is recognized for trusted, premium cannabis products and services in Canada It holds cultivation, processing and sales licenses from Health Canada and operates world-class state of the art indoor and seasonal cultivation facilities. VIVO has a collection of premium brands in Canada, each targeting different customer segments, including Canna Farms ™, Beacon Medical ™, Fireside ™, Fireside-X ™ and Lumina ™. Harvest Medicine ™, VIVO’s client-centric, scalable network of medical cannabis clinics, has serviced over 150,000 patient visits. VIVO is pursuing several partnership and product development opportunities and is focusing its international efforts on Germany and Australia.
For more information, visit: VIVO Cannabis Inc. and Beacon Medical Germany

Business partner

We invite you to join us as a partner with your resources and participate proactively in the supply chain of the German & EU medical cannabis market. A good medical alternative with fewer risks and side effects.
As a partner we can guarantee you security, continuity, transparency and trust.
Contact:
business(@)mp-resource(.)com
Internal forwarding: Click on “CONTINUE” please

Medical Pharma Resource boosts Beacon Medical Germany’s distribution network

Sky is the Limit!
Langenfeld, 09/30/2021

Beacon Medical Germany, a subsidiary of Canada’s VIVO Cannabis Inc. officially announced today that Medical Pharma Resource (Medical Pharma) GmbH is the first German company authorized to distribute VIVO’s premium cannabis products in Germany.

Medical Pharma is the exclusive distributor for medicinal cannabis flowers of the Beacon Medical products and additionally takes over the complete support handling to the pharmacies. Medical Pharma has already set up a health professional section and a hotline for pharmacies and will be the first point of contact for the professional staff for all concerns and questions about the Beacon products or also about “cannabis as medicine”.

“Realizing this exclusive cooperation and thus improving the selection and quality standard for German patients was a tough job. Negotiations, certification, import permits, etc. were made much more difficult by the restrictions of the Corona pandemic. But now we and the patients in Germany can reap the fruits of over two years of hard work,” says Engin Ates, the Co-Founder and CEO of Medical Pharma.

Medical Pharma has already started accepting non-binding advance orders. A product information brochure incl. PZN is available for download in the health professional section.

About VIVO Cannabis™
VIVO Cannabis is recognized for trusted, premium cannabis products and services. It holds cultivation, processing and sales licences from Health Canada and operates world-class indoor and seasonal cultivation facilities. VIVO has a collection of premium brands, each targeting different customer segments, including Canna Farms, Beacon Medical, Fireside, and Lumina. Harvest Medicine, VIVO’s client-centric, scalable network of medical cannabis clinics, has serviced over 150,000 patient visits. VIVO is pursuing several partnership and product development opportunities and is focusing its international efforts on Germany and Australia.

For more information visit: www.vivocannabis.com or www.beaconmedical.de

Source: Press release Beacon Medical Germany

 

Public Relations Medical Pharma Resource

Dr. Daniel König
+49 (0) 2173 940 95 91
presse(@)mp-resource(.)com

About Medical Pharma Resource ®

Medical Pharma Resource (Medical Pharma) GmbH was founded at the end of 2018 and is based in Langenfeld, Germany. The focus of this pharmaceutical company is the import and distribution of prescription medical cannabis products and applicators.
Since the foundation of the company in 2018, national and international cooperations with partners from logistics, narcotic warehousing, analyzing and producers have been concluded so that own products can also be introduced and distributed under the brand name “MPRCanna ®“.
Medical Pharma is a licensed pharmaceutical wholesaler according to § 52a of the German Medicines Act (AMG) and has the permission to handle narcotics according to § 3 of the German Narcotics Act (BtMG). Currently, Medical Pharma is preparing for the granting of the manufacturing license according to § 13 AMG incl. according to § 72 AMG.

The philosophy of Medical Pharma

The core of Medical Pharma philosophy is to provide patients with new high quality medicinal cannabis flowers.
Medical Pharma Resource GmbH has taken the goal to consider the criteria that are important for the well-being of patients when selecting manufacturers in order to ensure the highest level of quality, efficacy, transparency and availability.
The partner products, the own products and also selectively products of the German competitors can be offered via Medical Pharma’s own sales platform.
For more information, please visit: www.mp-resource.com

Business partner

We invite you to join us as a partner with your resources and participate proactively in the supply chain of the German & EU medical cannabis market. A good medical alternative with fewer risks and side effects.
As a partner we can guarantee you security, continuity, transparency and trust.
Contact:
business(@)mp-resource(.)com
Internal forwarding: Click on “CONTINUE” please
Privacy Settings
We use cookies to enhance your experience while using our website. If you are using our Services via a browser you can restrict, block or remove cookies through your web browser settings. We also use content and scripts from third parties that may use tracking technologies. You can selectively provide your consent below to allow such third party embeds. For complete information about the cookies we use, data we collect and how we process them, please check our Privacy Policy
Youtube
Consent to display content from Youtube
Vimeo
Consent to display content from Vimeo
Google Maps
Consent to display content from Google
error: Content is protected !! Sorry Buddy :)